By supporting OCC, you are creating a future where ovarian cancer is preventable, curable, and ultimately eradicated.
OCC convenes leading minds in the field of ovarian cancer research and provides the necessary resources to enable discoveries.
Just 25 years ago, there were only three scientists dedicated to the study of ovarian cancer. Through OCC’s efforts, the ovarian cancer research community is 250+ and growing.
Science requires collaboration to make the greatest impact and cannot be approached in silos.
Our Community is Unique
We only fund research that will best benefit the community and make the greatest impact
We implement a combination of standard competitive processes and collaborative, strategic decision-making
We foster innovation and allow for freedom of discovery
Precision medicine for patients with co-existent ovarian and endometrial cancer: the COMPARE trial
- Location
- Vancouver
- Lead scientist
- Dr. Amy Jamieson and Dr. Jessica McAlpine
- Type of ovarian cancer
- Endometrioid
- Research continuum
- Clinical trial
- Ovarian cancer continuum
- Treatment
Location
Vancouver
Lead scientist
Dr. Amy Jamieson and Dr. Jessica McAlpine
Type of ovarian cancer
Endometrioid
Research continuum
Implementation Real-world clinical data Mixed methods Research capacity Discovery research Pre-clinical Clinical trial
Ovarian cancer continuum
Detection/diagnosis Cancer biology Prevention Early detection Treatment Survivorship
Clonal hematopoiesis as a biomarker of poor prognosis in high-grade serous ovarian cancer
- Location
- Toronto
- Lead scientist
- Dr. Robert Vanner
- Type of ovarian cancer
- High-grade serous
- Research continuum
- Real-world clinical data
- Ovarian cancer continuum
- Treatment
Location
Toronto
Lead scientist
Dr. Robert Vanner
Type of ovarian cancer
High-grade serous
Research continuum
Implementation Real-world clinical data Mixed methods Research capacity Discovery research Pre-clinical Clinical trial
Ovarian cancer continuum
Detection/diagnosis Cancer biology Prevention Early detection Treatment Survivorship
Prevalence and Experience of Traumatic Stress in Patients with Newly Diagnosed and Recurrent Advanced Ovarian Cancer
- Location
- Toronto
- Lead scientist
- Dr. Stephanie Lheureux and Dr. Gary Rodin
- Type of ovarian cancer
- All types
- Research continuum
- Clinical trial
- Ovarian cancer continuum
- Survivorship
Location
Toronto
Lead scientist
Dr. Stephanie Lheureux and Dr. Gary Rodin
Type of ovarian cancer
All types
Research continuum
Implementation Real-world clinical data Mixed methods Research capacity Discovery research Pre-clinical Clinical trial
Ovarian cancer continuum
Detection/diagnosis Cancer biology Prevention Early detection Treatment Survivorship
Enabling a Phase I Clinical Trial of a Novel CAR-T Cell Therapy for Ovarian Cancer
- Location
- Victoria
- Lead scientist
- Dr. Brad Nelson and Dr. Jennifer Quizi
- Type of ovarian cancer
- All types
- Research continuum
- Pre-clinical
- Ovarian cancer continuum
- Treatment
Location
Victoria
Lead scientist
Dr. Brad Nelson and Dr. Jennifer Quizi
Type of ovarian cancer
All types
Research continuum
Implementation Real-world clinical data Mixed methods Research capacity Discovery research Pre-clinical Clinical trial
Ovarian cancer continuum
Detection/diagnosis Cancer biology Prevention Early detection Treatment Survivorship
Improving access to opportunistic salpingectomy in Canada: a collaboration with the Ovarian Cancer Observatory
- Location
- Vancouver
- Lead scientist
- Dr. Gillian Hanley and Dr. David Huntsman
- Type of ovarian cancer
- All types
- Research continuum
- Mixed methods
- Ovarian cancer continuum
- Prevention
Location
Vancouver
Lead scientist
Dr. Gillian Hanley and Dr. David Huntsman
Type of ovarian cancer
All types
Research continuum
Implementation Real-world clinical data Mixed methods Research capacity Discovery research Pre-clinical Clinical trial
Ovarian cancer continuum
Detection/diagnosis Cancer biology Prevention Early detection Treatment Survivorship
Development and characterization of humanized patient-derived xenograft models for ovarian cancer
- Location
- Vancouver
- Lead scientist
- Dr. David Huntsman
- Type of ovarian cancer
- All types
- Research continuum
- Research capacity
- Ovarian cancer continuum
- Treatment
Location
Vancouver
Lead scientist
Dr. David Huntsman
Type of ovarian cancer
All types
Research continuum
Implementation Real-world clinical data Mixed methods Research capacity Discovery research Pre-clinical Clinical trial
Ovarian cancer continuum
Detection/diagnosis Cancer biology Prevention Early detection Treatment Survivorship
Investigating the proteome and secretome of ovarian cancer to inform early detection and treatment
- Location
- Kingston
- Lead scientist
- Dr. Tyler Cooper
- Type of ovarian cancer
- All types
- Research continuum
- Pre-clinical
- Ovarian cancer continuum
- Detection/diagnosis Treatment
Location
Kingston
Lead scientist
Dr. Tyler Cooper
Type of ovarian cancer
All types
Research continuum
Implementation Real-world clinical data Mixed methods Research capacity Discovery research Pre-clinical Clinical trial
Ovarian cancer continuum
Detection/diagnosis Cancer biology Prevention Early detection Treatment Survivorship
Uncovering targetable interactions of ovarian cancer cells
- Location
- Toronto
- Lead scientist
- Dr. Curtis McCloskey
- Type of ovarian cancer
- High-grade serous
- Research continuum
- Pre-clinical
- Ovarian cancer continuum
- Prevention Treatment
Location
Toronto
Lead scientist
Dr. Curtis McCloskey
Type of ovarian cancer
High-grade serous
Research continuum
Implementation Real-world clinical data Mixed methods Research capacity Discovery research Pre-clinical Clinical trial
Ovarian cancer continuum
Detection/diagnosis Cancer biology Prevention Early detection Treatment Survivorship
Uncovering novel metabolic regulators of T cell function
- Location
- Victoria
- Lead scientist
- Sarah Mcphedran
- Type of ovarian cancer
- All types
- Research continuum
- Pre-clinical
- Ovarian cancer continuum
- Treatment
Location
Victoria
Lead scientist
Sarah Mcphedran
Type of ovarian cancer
All types
Research continuum
Implementation Real-world clinical data Mixed methods Research capacity Discovery research Pre-clinical Clinical trial
Ovarian cancer continuum
Detection/diagnosis Cancer biology Prevention Early detection Treatment Survivorship
Exploring the role of PARG in DNA repair and cancer
- Location
- Quebec City
- Lead scientist
- Nurgul Atalay
- Type of ovarian cancer
- High-grade serous
- Research continuum
- Pre-clinical
- Ovarian cancer continuum
- Treatment
Location
Quebec City
Lead scientist
Nurgul Atalay
Type of ovarian cancer
High-grade serous
Research continuum
Implementation Real-world clinical data Mixed methods Research capacity Discovery research Pre-clinical Clinical trial
Ovarian cancer continuum
Detection/diagnosis Cancer biology Prevention Early detection Treatment Survivorship
Investigating how a novel glycolipid drug kills chemotherapy-resistant ovarian cancer
- Location
- Winnipeg
- Lead scientist
- Dr. Mark Nachtigal
- Type of ovarian cancer
- High-grade serous
- Research continuum
- Pre-clinical
- Ovarian cancer continuum
- Treatment
Location
Winnipeg
Lead scientist
Dr. Mark Nachtigal
Type of ovarian cancer
High-grade serous
Research continuum
Implementation Real-world clinical data Mixed methods Research capacity Discovery research Pre-clinical Clinical trial
Ovarian cancer continuum
Detection/diagnosis Cancer biology Prevention Early detection Treatment Survivorship
A new approach to sustained, local, immunotherapy for ovarian cancer
- Location
- Halifax
- Lead scientist
- Dr. Jean Marshall
- Type of ovarian cancer
- All types
- Research continuum
- Pre-clinical
- Ovarian cancer continuum
- Treatment
Location
Halifax
Lead scientist
Dr. Jean Marshall
Type of ovarian cancer
All types
Research continuum
Implementation Real-world clinical data Mixed methods Research capacity Discovery research Pre-clinical Clinical trial
Ovarian cancer continuum
Detection/diagnosis Cancer biology Prevention Early detection Treatment Survivorship
Charting the cellular spacial landscape in rare ovarian cancer
- Location
- Montreal
- Lead scientist
- Dr. Diane Provencher
- Type of ovarian cancer
- Low-grade serous Endometrioid Clear cell Mucinous Rare types
- Research continuum
- Discovery research
- Ovarian cancer continuum
- Cancer biology
Location
Montreal
Lead scientist
Dr. Diane Provencher
Type of ovarian cancer
Low-grade serous Endometrioid Clear cell Mucinous Rare types
Research continuum
Implementation Real-world clinical data Mixed methods Research capacity Discovery research Pre-clinical Clinical trial
Ovarian cancer continuum
Detection/diagnosis Cancer biology Prevention Early detection Treatment Survivorship
Identifying biomarkers of immunotherapy response in ovarian clear cell carcinoma
- Location
- Montreal
- Lead scientist
- Dr. Melica Brodeur
- Type of ovarian cancer
- Clear cell
- Research continuum
- Discovery research
- Ovarian cancer continuum
- Treatment
Location
Montreal
Lead scientist
Dr. Melica Brodeur
Type of ovarian cancer
Clear cell
Research continuum
Implementation Real-world clinical data Mixed methods Research capacity Discovery research Pre-clinical Clinical trial
Ovarian cancer continuum
Detection/diagnosis Cancer biology Prevention Early detection Treatment Survivorship
Adapting the Genetics Adviser digital app to support cascade testing
- Location
- Toronto
- Lead scientist
- Dr. Yvonne Bombard
- Type of ovarian cancer
- All types
- Research continuum
- Mixed methods
- Ovarian cancer continuum
- Prevention
Location
Toronto
Lead scientist
Dr. Yvonne Bombard
Type of ovarian cancer
All types
Research continuum
Implementation Real-world clinical data Mixed methods Research capacity Discovery research Pre-clinical Clinical trial
Ovarian cancer continuum
Detection/diagnosis Cancer biology Prevention Early detection Treatment Survivorship
Evaluation of novel parent-of-origin detection sequencing tool
- Location
- Vancouver
- Lead scientist
- Dr. Intan Schrader
- Type of ovarian cancer
- All types
- Research continuum
- Mixed methods
- Ovarian cancer continuum
- Prevention
Location
Vancouver
Lead scientist
Dr. Intan Schrader
Type of ovarian cancer
All types
Research continuum
Implementation Real-world clinical data Mixed methods Research capacity Discovery research Pre-clinical Clinical trial
Ovarian cancer continuum
Detection/diagnosis Cancer biology Prevention Early detection Treatment Survivorship
Nova Scotia Ovarian Cancer Biobank
- Location
- Halifax
- Lead scientist
- Dr. Stephanie Scott
- Type of ovarian cancer
- All types
- Research continuum
- Research capacity
- Ovarian cancer continuum
- Detection/diagnosis Cancer biology Treatment
Location
Halifax
Lead scientist
Dr. Stephanie Scott
Type of ovarian cancer
All types
Research continuum
Implementation Real-world clinical data Mixed methods Research capacity Discovery research Pre-clinical Clinical trial
Ovarian cancer continuum
Detection/diagnosis Cancer biology Prevention Early detection Treatment Survivorship
Using population-based data to understand ovarian cancer care and outcomes in Nova Scotia
- Location
- Halifax
- Lead scientist
- Dr. Robin Urquhart
- Type of ovarian cancer
- All types
- Research continuum
- Real-world clinical data
- Ovarian cancer continuum
- Detection/diagnosis
Location
Halifax
Lead scientist
Dr. Robin Urquhart
Type of ovarian cancer
All types
Research continuum
Implementation Real-world clinical data Mixed methods Research capacity Discovery research Pre-clinical Clinical trial
Ovarian cancer continuum
Detection/diagnosis Cancer biology Prevention Early detection Treatment Survivorship
Ovarian Cancer in Nova Scotian patients: Studying tumour genetics and immune cell interactions over time to unlock new treatment opportunities
- Location
- Halifax
- Lead scientist
- Dr. Jeanette Boudreau
- Type of ovarian cancer
- All types
- Research continuum
- Pre-clinical
- Ovarian cancer continuum
- Treatment
Location
Halifax
Lead scientist
Dr. Jeanette Boudreau
Type of ovarian cancer
All types
Research continuum
Implementation Real-world clinical data Mixed methods Research capacity Discovery research Pre-clinical Clinical trial
Ovarian cancer continuum
Detection/diagnosis Cancer biology Prevention Early detection Treatment Survivorship
Implementation of patient-oriented Folate Receptor Alpha reporting
- Location
- Saskatoon
- Lead scientist
- Dr. Marilyn Kinloch
- Type of ovarian cancer
- High-grade serous
- Research continuum
- Implementation
- Ovarian cancer continuum
- Treatment
Location
Saskatoon
Lead scientist
Dr. Marilyn Kinloch
Type of ovarian cancer
High-grade serous
Research continuum
Implementation Real-world clinical data Mixed methods Research capacity Discovery research Pre-clinical Clinical trial
Ovarian cancer continuum
Detection/diagnosis Cancer biology Prevention Early detection Treatment Survivorship
Enhancement of the University of Saskatchewan Gynecologic Oncology Biobank
- Location
- Saskatoon
- Lead scientist
- Dr. Marilyn Kinloch
- Type of ovarian cancer
- All types
- Research continuum
- Research capacity
- Ovarian cancer continuum
- Detection/diagnosis Cancer biology Treatment
Location
Saskatoon
Lead scientist
Dr. Marilyn Kinloch
Type of ovarian cancer
All types
Research continuum
Implementation Real-world clinical data Mixed methods Research capacity Discovery research Pre-clinical Clinical trial
Ovarian cancer continuum
Detection/diagnosis Cancer biology Prevention Early detection Treatment Survivorship
Effect of intravenous iron infusion on the prevention and treatment of anemia in ovarian cancer
- Location
- Regina
- Lead scientist
- Dr. Maryam Al-Hayki
- Type of ovarian cancer
- All types
- Research continuum
- Clinical trial
- Ovarian cancer continuum
- Treatment
Location
Regina
Lead scientist
Dr. Maryam Al-Hayki
Type of ovarian cancer
All types
Research continuum
Implementation Real-world clinical data Mixed methods Research capacity Discovery research Pre-clinical Clinical trial
Ovarian cancer continuum
Detection/diagnosis Cancer biology Prevention Early detection Treatment Survivorship
Testing a novel treatment target in clear cell ovarian cancer
- Location
- Vancouver
- Lead scientist
- Dr. David Huntsman
- Type of ovarian cancer
- Clear cell
- Research continuum
- Pre-clinical
- Ovarian cancer continuum
- Treatment
Location
Vancouver
Lead scientist
Dr. David Huntsman
Type of ovarian cancer
Clear cell
Research continuum
Implementation Real-world clinical data Mixed methods Research capacity Discovery research Pre-clinical Clinical trial
Ovarian cancer continuum
Detection/diagnosis Cancer biology Prevention Early detection Treatment Survivorship
Establishing a national registry of clear cell and mucinous ovarian cancers
- Location
- Vancouver
- Lead scientist
- Dr. Mark Carey
- Type of ovarian cancer
- Clear cell Mucinous Rare types
- Research continuum
- Research capacity
- Ovarian cancer continuum
- Treatment
Location
Vancouver
Lead scientist
Dr. Mark Carey
Type of ovarian cancer
Clear cell Mucinous Rare types
Research continuum
Implementation Real-world clinical data Mixed methods Research capacity Discovery research Pre-clinical Clinical trial
Ovarian cancer continuum
Detection/diagnosis Cancer biology Prevention Early detection Treatment Survivorship
Anti-estrogen therapy and ER/PR expression in low-grade serous ovarian cancer
- Location
- Vancouver
- Lead scientist
- Dr. Mark Carey
- Type of ovarian cancer
- Low-grade serous
- Research continuum
- Pre-clinical
- Ovarian cancer continuum
- Treatment
Location
Vancouver
Lead scientist
Dr. Mark Carey
Type of ovarian cancer
Low-grade serous
Research continuum
Implementation Real-world clinical data Mixed methods Research capacity Discovery research Pre-clinical Clinical trial
Ovarian cancer continuum
Detection/diagnosis Cancer biology Prevention Early detection Treatment Survivorship
Patient-derived xenograft models of rare estrogen receptor-positive ovarian cancers
- Location
- Vancouver
- Lead scientist
- Dr. Mark Carey
- Type of ovarian cancer
- Low-grade serous
- Research continuum
- Research capacity
- Ovarian cancer continuum
- Treatment
Location
Vancouver
Lead scientist
Dr. Mark Carey
Type of ovarian cancer
Low-grade serous
Research continuum
Implementation Real-world clinical data Mixed methods Research capacity Discovery research Pre-clinical Clinical trial
Ovarian cancer continuum
Detection/diagnosis Cancer biology Prevention Early detection Treatment Survivorship
Molecular and Functional Characterization of a Patient-Derived Organoid Platform for Ovarian Cancer
- Location
- Ottawa
- Lead scientist
- Dr. David Cook
- Type of ovarian cancer
- Low-grade serous Clear cell
- Research continuum
- Research capacity
- Ovarian cancer continuum
- Treatment
Location
Ottawa
Lead scientist
Dr. David Cook
Type of ovarian cancer
Low-grade serous Clear cell
Research continuum
Implementation Real-world clinical data Mixed methods Research capacity Discovery research Pre-clinical Clinical trial
Ovarian cancer continuum
Detection/diagnosis Cancer biology Prevention Early detection Treatment Survivorship
Testing a novel HER2-targeted combination treatment for ovarian cancer
- Location
- Ottawa
- Lead scientist
- Dr. Jean-Simon Diallo
- Type of ovarian cancer
- All types
- Research continuum
- Pre-clinical
- Ovarian cancer continuum
- Treatment
Location
Ottawa
Lead scientist
Dr. Jean-Simon Diallo
Type of ovarian cancer
All types
Research continuum
Implementation Real-world clinical data Mixed methods Research capacity Discovery research Pre-clinical Clinical trial
Ovarian cancer continuum
Detection/diagnosis Cancer biology Prevention Early detection Treatment Survivorship
Syngeneic mouse models: tools to study immune-based treatments for ovarian cancer
- Location
- Ottawa
- Lead scientist
- Dr. Barbara Vanderhyden
- Type of ovarian cancer
- High-grade serous
- Research continuum
- Research capacity
- Ovarian cancer continuum
- Cancer biology
Location
Ottawa
Lead scientist
Dr. Barbara Vanderhyden
Type of ovarian cancer
High-grade serous
Research continuum
Implementation Real-world clinical data Mixed methods Research capacity Discovery research Pre-clinical Clinical trial
Ovarian cancer continuum
Detection/diagnosis Cancer biology Prevention Early detection Treatment Survivorship
Exploring a new therapeutic approach for rare ovarian cancers
- Location
- Montreal
- Lead scientist
- Dr. Anne-Marie Mes-Masson
- Type of ovarian cancer
- Rare types
- Research continuum
- Pre-clinical
- Ovarian cancer continuum
- Treatment
Location
Montreal
Lead scientist
Dr. Anne-Marie Mes-Masson
Type of ovarian cancer
Rare types
Research continuum
Implementation Real-world clinical data Mixed methods Research capacity Discovery research Pre-clinical Clinical trial
Ovarian cancer continuum
Detection/diagnosis Cancer biology Prevention Early detection Treatment Survivorship
Understanding and targeting single-stranded DNA gap-filling mechanisms to improve chemotherapy response
- Location
- Sherbrooke
- Lead scientist
- Dr. Alexandre Maréchal
- Type of ovarian cancer
- All types
- Research continuum
- Pre-clinical
- Ovarian cancer continuum
- Treatment
Location
Sherbrooke
Lead scientist
Dr. Alexandre Maréchal
Type of ovarian cancer
All types
Research continuum
Implementation Real-world clinical data Mixed methods Research capacity Discovery research Pre-clinical Clinical trial
Ovarian cancer continuum
Detection/diagnosis Cancer biology Prevention Early detection Treatment Survivorship
Investigating the “surfaceome” to discover new treatments for rare ovarian cancers
- Location
- Vancouver
- Lead scientist
- Dr. Yemin Wang
- Type of ovarian cancer
- Rare types
- Research continuum
- Pre-clinical
- Ovarian cancer continuum
- Treatment
Location
Vancouver
Lead scientist
Dr. Yemin Wang
Type of ovarian cancer
Rare types
Research continuum
Implementation Real-world clinical data Mixed methods Research capacity Discovery research Pre-clinical Clinical trial
Ovarian cancer continuum
Detection/diagnosis Cancer biology Prevention Early detection Treatment Survivorship
Understanding how glycosylated antitumour ether lipids (GAELs) kill chemotherapy-resistant cancer cells
- Location
- Winnipeg
- Lead scientist
- Sara Crooks (Dr. Mark Nachtigal)
- Type of ovarian cancer
- High-grade serous
- Research continuum
- Pre-clinical
- Ovarian cancer continuum
- Treatment
Location
Winnipeg
Lead scientist
Sara Crooks (Dr. Mark Nachtigal)
Type of ovarian cancer
High-grade serous
Research continuum
Implementation Real-world clinical data Mixed methods Research capacity Discovery research Pre-clinical Clinical trial
Ovarian cancer continuum
Detection/diagnosis Cancer biology Prevention Early detection Treatment Survivorship
Remodeling the immune microenvironment of ovarian cancer using oncolytic viruses
- Location
- Sherbrooke
- Lead scientist
- Zacharie Drouin (Dr. Marilyne Labrie)
- Type of ovarian cancer
- All types
- Research continuum
- Pre-clinical
- Ovarian cancer continuum
- Treatment
Location
Sherbrooke
Lead scientist
Zacharie Drouin (Dr. Marilyne Labrie)
Type of ovarian cancer
All types
Research continuum
Implementation Real-world clinical data Mixed methods Research capacity Discovery research Pre-clinical Clinical trial
Ovarian cancer continuum
Detection/diagnosis Cancer biology Prevention Early detection Treatment Survivorship
Metabolic engineering of CAR-T cells to overcome immune suppression
- Location
- Victoria
- Lead scientist
- Jessica Morgan (Julian Lum)
- Type of ovarian cancer
- High-grade serous
- Research continuum
- Pre-clinical
- Ovarian cancer continuum
- Treatment
Location
Victoria
Lead scientist
Jessica Morgan (Julian Lum)
Type of ovarian cancer
High-grade serous
Research continuum
Implementation Real-world clinical data Mixed methods Research capacity Discovery research Pre-clinical Clinical trial
Ovarian cancer continuum
Detection/diagnosis Cancer biology Prevention Early detection Treatment Survivorship
Metabolic Gene-Edited CAR-T Cells For Ovarian Cancer Treatment
- Location
- Victoria
- Lead scientist
- Dr. Julian Lum
- Type of ovarian cancer
- All types
- Research continuum
- Pre-clinical
- Ovarian cancer continuum
- Treatment
Location
Victoria
Lead scientist
Dr. Julian Lum
Type of ovarian cancer
All types
Research continuum
Implementation Real-world clinical data Mixed methods Research capacity Discovery research Pre-clinical Clinical trial
Ovarian cancer continuum
Detection/diagnosis Cancer biology Prevention Early detection Treatment Survivorship
Optimizing an off-the shelf ovarian cancer RNA vaccine
- Location
- Montreal
- Lead scientist
- Dr. Claude Perreault
- Type of ovarian cancer
- All types
- Research continuum
- Pre-clinical
- Ovarian cancer continuum
- Treatment
Location
Montreal
Lead scientist
Dr. Claude Perreault
Type of ovarian cancer
All types
Research continuum
Implementation Real-world clinical data Mixed methods Research capacity Discovery research Pre-clinical Clinical trial
Ovarian cancer continuum
Detection/diagnosis Cancer biology Prevention Early detection Treatment Survivorship
Fallopian imaging and lavage for early-stage tubo-ovarian cancer detection
- Location
- Vancouver
- Lead scientist
- Dr. Andrea Neilson
- Type of ovarian cancer
- High-grade serous
- Research continuum
- Pre-clinical
- Ovarian cancer continuum
- Early detection
Location
Vancouver
Lead scientist
Dr. Andrea Neilson
Type of ovarian cancer
High-grade serous
Research continuum
Implementation Real-world clinical data Mixed methods Research capacity Discovery research Pre-clinical Clinical trial
Ovarian cancer continuum
Detection/diagnosis Cancer biology Prevention Early detection Treatment Survivorship
The earlier detection of ovarian cancer using an mDETECT liquid biopsy
- Location
- Kingston
- Lead scientist
- Dr. Christopher Mueller
- Type of ovarian cancer
- All types
- Research continuum
- Pre-clinical
- Ovarian cancer continuum
- Early detection
Location
Kingston
Lead scientist
Dr. Christopher Mueller
Type of ovarian cancer
All types
Research continuum
Implementation Real-world clinical data Mixed methods Research capacity Discovery research Pre-clinical Clinical trial
Ovarian cancer continuum
Detection/diagnosis Cancer biology Prevention Early detection Treatment Survivorship
Using patient-derived models and drug sensitivity testing to guide personalized medicine: a proof-of-concept trial
- Location
- Saskatooon
- Lead scientist
- Dr. Laura Hopkins
- Type of ovarian cancer
- All types
- Research continuum
- Clinical trial
- Ovarian cancer continuum
- Treatment
Location
Saskatooon
Lead scientist
Dr. Laura Hopkins
Type of ovarian cancer
All types
Research continuum
Implementation Real-world clinical data Mixed methods Research capacity Discovery research Pre-clinical Clinical trial
Ovarian cancer continuum
Detection/diagnosis Cancer biology Prevention Early detection Treatment Survivorship
ES2 trial: combining a PARP inhibitor and apoptosis sensitizer
- Location
- Montreal
- Lead scientist
- Dr. Diane Provencher
- Type of ovarian cancer
- High-grade serous
- Research continuum
- Clinical trial
- Ovarian cancer continuum
- Treatment
Location
Montreal
Lead scientist
Dr. Diane Provencher
Type of ovarian cancer
High-grade serous
Research continuum
Implementation Real-world clinical data Mixed methods Research capacity Discovery research Pre-clinical Clinical trial
Ovarian cancer continuum
Detection/diagnosis Cancer biology Prevention Early detection Treatment Survivorship
Supercharging CAR-T cells for Ovarian Cancer
- Location
- Victoria
- Lead scientist
- Dr. Brad Nelson
- Type of ovarian cancer
- All types
- Research continuum
- Pre-clinical
- Ovarian cancer continuum
- Treatment
Location
Victoria
Lead scientist
Dr. Brad Nelson
Type of ovarian cancer
All types
Research continuum
Implementation Real-world clinical data Mixed methods Research capacity Discovery research Pre-clinical Clinical trial
Ovarian cancer continuum
Detection/diagnosis Cancer biology Prevention Early detection Treatment Survivorship
Building a scientific toolbox to study low-grade serous ovarian cancer
- Location
- Vancouver
- Lead scientist
- Dr. Mark Carey
- Type of ovarian cancer
- Low-grade serous
- Research continuum
- Research capacity
- Ovarian cancer continuum
- Cancer biology
Location
Vancouver
Lead scientist
Dr. Mark Carey
Type of ovarian cancer
Low-grade serous
Research continuum
Implementation Real-world clinical data Mixed methods Research capacity Discovery research Pre-clinical Clinical trial
Ovarian cancer continuum
Detection/diagnosis Cancer biology Prevention Early detection Treatment Survivorship
Tumour testing and ovarian cancer drug prediction program
- Location
- Saskatoon
- Lead scientist
- Dr. Laura Hopkins
- Type of ovarian cancer
- High-grade serous
- Research continuum
- Clinical trial
- Ovarian cancer continuum
- Treatment
Location
Saskatoon
Lead scientist
Dr. Laura Hopkins
Type of ovarian cancer
High-grade serous
Research continuum
Implementation Real-world clinical data Mixed methods Research capacity Discovery research Pre-clinical Clinical trial
Ovarian cancer continuum
Detection/diagnosis Cancer biology Prevention Early detection Treatment Survivorship
Every Woman Study: Canadian Edition
- Location
- Toronto [pan-Canadian]
- Lead scientist
- Ovarian Cancer Canada
- Type of ovarian cancer
- All types
- Research continuum
- Discovery research
- Ovarian cancer continuum
- Treatment Survivorship
Location
Toronto [pan-Canadian]
Lead scientist
Ovarian Cancer Canada
Type of ovarian cancer
All types
Research continuum
Implementation Real-world clinical data Mixed methods Research capacity Discovery research Pre-clinical Clinical trial
Ovarian cancer continuum
Detection/diagnosis Cancer biology Prevention Early detection Treatment Survivorship
Phase II clinical trial of CX5461 at the time of disease progression on a PARP inhibitor
- Location
- Toronto
- Lead scientist
- Dr. Amit Oza
- Type of ovarian cancer
- High-grade serous
- Research continuum
- Clinical trial
- Ovarian cancer continuum
- Treatment
Location
Toronto
Lead scientist
Dr. Amit Oza
Type of ovarian cancer
High-grade serous
Research continuum
Implementation Real-world clinical data Mixed methods Research capacity Discovery research Pre-clinical Clinical trial
Ovarian cancer continuum
Detection/diagnosis Cancer biology Prevention Early detection Treatment Survivorship
Exploring and exploiting aberrant RBX1 expression in high-grade serous ovarian cancer
- Location
- Winnipeg
- Lead scientist
- Dr. Kirk McManus
- Type of ovarian cancer
- High-grade serous
- Research continuum
- Pre-clinical
- Ovarian cancer continuum
- Cancer biology
Location
Winnipeg
Lead scientist
Dr. Kirk McManus
Type of ovarian cancer
High-grade serous
Research continuum
Implementation Real-world clinical data Mixed methods Research capacity Discovery research Pre-clinical Clinical trial
Ovarian cancer continuum
Detection/diagnosis Cancer biology Prevention Early detection Treatment Survivorship
Understanding the experience of previvors receiving care at a specialized centre
- Location
- Vancouver
- Lead scientist
- Dr. Lesa Dawson
- Type of ovarian cancer
- High-grade serous
- Research continuum
- Discovery research
- Ovarian cancer continuum
- Prevention
Location
Vancouver
Lead scientist
Dr. Lesa Dawson
Type of ovarian cancer
High-grade serous
Research continuum
Implementation Real-world clinical data Mixed methods Research capacity Discovery research Pre-clinical Clinical trial
Ovarian cancer continuum
Detection/diagnosis Cancer biology Prevention Early detection Treatment Survivorship
Targeting epitranscriptomic mechanisms in ovarian cancer
- Location
- Edmonton
- Lead scientist
- Dr. YangXin Fu
- Type of ovarian cancer
- All types
- Research continuum
- Pre-clinical
- Ovarian cancer continuum
- Treatment
Location
Edmonton
Lead scientist
Dr. YangXin Fu
Type of ovarian cancer
All types
Research continuum
Implementation Real-world clinical data Mixed methods Research capacity Discovery research Pre-clinical Clinical trial
Ovarian cancer continuum
Detection/diagnosis Cancer biology Prevention Early detection Treatment Survivorship
CHARM Early Detection Clinical Trial
- Location
- Toronto
- Lead scientist
- Dr. Trevor Pugh
- Type of ovarian cancer
- High-grade serous Endometrioid Clear cell
- Research continuum
- Clinical trial
- Ovarian cancer continuum
- Early detection
Location
Toronto
Lead scientist
Dr. Trevor Pugh
Type of ovarian cancer
High-grade serous Endometrioid Clear cell
Research continuum
Implementation Real-world clinical data Mixed methods Research capacity Discovery research Pre-clinical Clinical trial
Ovarian cancer continuum
Detection/diagnosis Cancer biology Prevention Early detection Treatment Survivorship
Developing new treatments for clear cell ovarian cancer
- Location
- Saskatoon
- Lead scientist
- Dr. Franco Vizeacoumar
- Type of ovarian cancer
- Clear cell
- Research continuum
- Pre-clinical
- Ovarian cancer continuum
- Treatment
Location
Saskatoon
Lead scientist
Dr. Franco Vizeacoumar
Type of ovarian cancer
Clear cell
Research continuum
Implementation Real-world clinical data Mixed methods Research capacity Discovery research Pre-clinical Clinical trial
Ovarian cancer continuum
Detection/diagnosis Cancer biology Prevention Early detection Treatment Survivorship
Developing optimal treatment combinations for small cell carcinoma of the ovary
- Location
- Montreal
- Lead scientist
- Dr. Sidong Huang
- Type of ovarian cancer
- Non-epithelial
- Research continuum
- Pre-clinical
- Ovarian cancer continuum
- Treatment
Location
Montreal
Lead scientist
Dr. Sidong Huang
Type of ovarian cancer
Non-epithelial
Research continuum
Implementation Real-world clinical data Mixed methods Research capacity Discovery research Pre-clinical Clinical trial
Ovarian cancer continuum
Detection/diagnosis Cancer biology Prevention Early detection Treatment Survivorship
Development of therapeutic vaccines against ovarian cancer
- Location
- Montreal
- Lead scientist
- Dr. Claude Perreault
- Type of ovarian cancer
- All types
- Research continuum
- Pre-clinical
- Ovarian cancer continuum
- Treatment
Location
Montreal
Lead scientist
Dr. Claude Perreault
Type of ovarian cancer
All types
Research continuum
Implementation Real-world clinical data Mixed methods Research capacity Discovery research Pre-clinical Clinical trial
Ovarian cancer continuum
Detection/diagnosis Cancer biology Prevention Early detection Treatment Survivorship
Re-VOLVE trial: using genomics to make treatment decisions after a PARP inhibitor
- Location
- Toronto
- Lead scientist
- Dr. Stephanie Lheureux
- Type of ovarian cancer
- High-grade serous Endometrioid
- Research continuum
- Clinical trial
- Ovarian cancer continuum
- Treatment
Location
Toronto
Lead scientist
Dr. Stephanie Lheureux
Type of ovarian cancer
High-grade serous Endometrioid
Research continuum
Implementation Real-world clinical data Mixed methods Research capacity Discovery research Pre-clinical Clinical trial
Ovarian cancer continuum
Detection/diagnosis Cancer biology Prevention Early detection Treatment Survivorship
A novel model system to study ovarian cancer/immune cell interactions
- Location
- Halifax
- Lead scientist
- Dr. Jeanette Boudreau
- Type of ovarian cancer
- All types
- Research continuum
- Research capacity
- Ovarian cancer continuum
- Cancer biology
Location
Halifax
Lead scientist
Dr. Jeanette Boudreau
Type of ovarian cancer
All types
Research continuum
Implementation Real-world clinical data Mixed methods Research capacity Discovery research Pre-clinical Clinical trial
Ovarian cancer continuum
Detection/diagnosis Cancer biology Prevention Early detection Treatment Survivorship
Modelling low-grade serous cancer in 3D
- Location
- Vancouver
- Lead scientist
- Dr. Mark Carey
- Type of ovarian cancer
- Low-grade serous
- Research continuum
- Research capacity
- Ovarian cancer continuum
- Cancer biology
Location
Vancouver
Lead scientist
Dr. Mark Carey
Type of ovarian cancer
Low-grade serous
Research continuum
Implementation Real-world clinical data Mixed methods Research capacity Discovery research Pre-clinical Clinical trial
Ovarian cancer continuum
Detection/diagnosis Cancer biology Prevention Early detection Treatment Survivorship